IND

Example Definitions of "IND"
IND. Shall mean an investigational new drug application, clinical study application, clinical trial exemption or similar application or submission for approval to conduct human clinical investigations filed with a Regulatory Authority in any country.
Found in TETRALOGIC PHARMACEUTICALS CORP contract
IND. Shall The term "IND" shall mean an investigational new drug application, clinical study trial application, clinical trial exemption exemption, or similar application or submission for approval to conduct human clinical investigations filed with or submitted to a Regulatory Authority regulatory authority in any country.
Found in Vividion Therapeutics, Inc. contract
IND. Shall mean an An investigational new drug application, clinical study application, clinical trial exemption or similar application or submission for approval to conduct human clinical investigations filed with a Regulatory Authority in any country. Authority.
Found in GENOCEA BIOSCIENCES, INC. contract
IND. Shall mean an investigational new drug An FDA Investigational New Drug application, clinical study application, clinical trial exemption Clinical Study Application, Clinical Trial Exemption, or similar application or submission for approval to conduct human clinical investigations filed with or submitted to a Regulatory Regulator Authority in any country. country in conformance with the requirements of such Regulatory Authority.
Found in TETRAPHASE PHARMACEUTICALS INC contract
View Variations (3)
IND. The Investigational New Drug Application filed or to be filed with the FDA as described in Title 21 of the U.S. Code of Federal Regulations, Part 312, and the equivalent application in the jurisdictions outside the United States, including an Investigational Medicinal Product Dossier filed or to be filed with the EMA.
Found in Replimune Group, Inc. contract
IND. The Investigational New Drug Application filed or to be filed with the FDA as described in Title 21 of the U.S. Code of Federal Regulations, Part 312, and the equivalent application in the jurisdictions outside the United States, including an Investigational Medicinal Product Dossier filed or to be filed with the EMA. States.
Found in Syndax Pharmaceuticals Inc contract
IND. The Investigational New Drug Application filed or to be filed with the FDA as described in Title 21 of the U.S. Code of Federal Regulations, Part 312, and the equivalent application in the jurisdictions outside the United States, including an Investigational Medicinal Product Dossier filed or to be filed with the EMA. Regulatory Authorities in the European Union.
Found in Syndax Pharmaceuticals Inc contract
IND. The Means the Investigational New Drug Application filed or to be filed with the FDA as described in Title 21 of the U.S. Code of Federal Regulations, Part 312, and the equivalent application in the jurisdictions outside the United States, including an Investigational "Investigational Medicinal Product Dossier Dossier" filed or to be filed with the EMA.
Found in Advaxis, Inc. contract
View Variations (3)
IND. Means an Investigational NDA in the Territory filed with the FDA.
Found in Vanda Pharmaceuticals Inc. contract
IND. Means an Investigational NDA New Drug application in the Territory filed with the FDA.
Found in Retrophin, Inc. contract
View Variation
IND. Means an investigational new drug application as defined in the FD&C Act and applicable regulations promulgated thereunder by the FDA or (b) the equivalent application to the equivalent Regulatory Authority in any other regulatory jurisdiction, the filing of which is necessary to initiate or conduct clinical testing of a pharmaceutical product in humans in such jurisdiction.
Found in Prometheus Biosciences, Inc. contract
IND. Means (a) an investigational new drug application Investigational New Drug Application as defined in the FD&C Act and applicable regulations promulgated thereunder by the FDA FDA, or (b) the equivalent application to the equivalent Regulatory Authority agency in any other regulatory jurisdiction, the filing of which is necessary to initiate or conduct clinical testing of a pharmaceutical product in humans in such jurisdiction. jurisdiction
Found in Repligen Corporation contract
View Variation
IND. An Investigational New Drug application required to commence human clinical testing of a product submitted to the FDA
Found in HARROW HEALTH, INC. contract
IND. An Investigational New Drug application or similar application required to commence human clinical testing of a product submitted to the FDA FDA, or its foreign equivalent
Found in INTREXON CORP contract
View Variation
IND. An Investigational New Drug application for a Licensed Product submitted to the FDA or a comparable application submitted to another Regulatory Agency.
Found in KERYX BIOPHARMACEUTICALS INC contract
IND. An investigational new drug application (Form FDA 1571) or any successor form or foreign equivalent.
Found in DNIB UNWIND, INC. contract
IND. An investigational new drug application and associated documents required to be filed with the FDA or a comparable government agency outside of the United States to obtain approval to commence human clinical trials of a Product.
Found in NEUROBIOLOGICAL TECHNOLOGIES INC contract
IND. The designation of Licensed Product as an Investigational New Drug on the basis of a Cell Cure-initiated application as described in 21 C.F.R. Section 312.23, filed for purposes of conducting a Phase I Clinical Trial in accordance with the requirements of the United States Food, Drug and Cosmetic Act of 1938, as amended, and the rules and regulations promulgated thereunder, including all supplements and amendments thereto, which may include, inter alia, managing animal studies, as well as... toxicology studies. View More
Found in BIOTIME INC contract
IND. The term "IND" shall mean an investigational new drug application as defined by 21 CFR Part 312.
Found in Sorrento Therapeutics, Inc. contract
All Definitions